Trial Profile
Compassionate Use of Stiripentol in Intractable Epilepsy Due to Dravet Syndrome.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary)
- Indications Dravet syndrome; Epilepsy
- Focus Expanded access; Therapeutic Use
- 27 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Feb 2012 New trial record